Literature DB >> 11208917

Site of injury-directed induction of heme oxygenase-1 and -2 in experimental spinal cord injury: differential functions in neuronal defense mechanisms?

N Panahian1, M D Maines.   

Abstract

The heme oxygenase (HO) isozymes catalyze oxidation of the heme molecule to biliverdin and carbon monoxide (CO) with the release of chelated iron. Presently, we have defined, for the first time, propensity for site of injury-directed induction of isozymes--the stress-inducible isozyme, HO-1, responds distal (below) and the glucocorticoid (GC)-inducible HO-2 responds proximal (above) to the site of injury. We have also shown that reactive iron (Fe3+) and cGMP staining spatially resemble that of HO-1; which, in turn, colocalizes in motor neurons with transcription factors: Fas-associated protein containing death domain (FADD), tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and p53. Spinal cord injury (SCI) was inflicted by clip compression for 30 min, and analyses were carried out after 4 h or 16 h. When compared with spinal cord segments proximal to the site of injury, northern blot analysis showed remarkably higher levels of HO-1 mRNA distal (below) to the site of injury at both time points. In contrast, HO-2 mRNA levels were elevated proximal (above) to the site of injury and more prominently at 16 h post SCI. Immunohistochemical analyses were carried out using 2 x 5 mm segments above and below the compression site. When compared with segments above the site of injury, the intensity of HO-1 immunostaining and the number of HO-1 positive neurons in the ventral horn motor neurons were prominently increased in segments below the injury. Western blot analysis confirmed the observations. HO-2 protein was mapped to the ventral horn motor neurons, oligodendrocytes, the Clarke's nucleus neurons and the ependymal cells. When compared with segments below the site of injury, neuronal HO-2 staining intensity was increased above the site of injury, and most notably at 16 h. These observations were also confirmed by western blotting and HO activity measurements. Tissue Fe3+ and cGMP staining were increased and prominently mapped below the site of injury, where cGMP colocalized with HO-1 in the nucleus of the motor neurons. Also, a site of injury-directed pattern of induction of FADD, TRAIL, and p53 immunoreactivity, and a widespread colocalization of the oncogenes with HO-1 protein, were found within motor neurons below the level of injury. We forward the hypothesis that HO-1 and HO-2 have different roles in the defense mechanisms of the injured nervous system. We hypothesize that HO-1 protects against further damage by contributing to controlled cell death through their intrinsic suicide program, while HO-2 is involved in suppression of inflammatory response by NO derived radicals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11208917     DOI: 10.1046/j.1471-4159.2001.00023.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration.

Authors:  Warin Krityakiarana; Paul M Zhao; Kevin Nguyen; Fernando Gomez-Pinilla; Naiphinich Kotchabhakdi; Jean de Vellis; Araceli Espinosa-Jeffrey
Journal:  Neurochem Res       Date:  2016-02-17       Impact factor: 3.996

2.  The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.

Authors:  Bo Ding; Peter E M Gibbs; Paul S Brookes; Mahin D Maines
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

3.  Differential sensitivity of oligodendrocytes and motor neurons to reactive nitrogen species: implications for multiple sclerosis.

Authors:  Amy Bishop; Kimberly Green Hobbs; Asuka Eguchi; Stephanie Jeffrey; Lorraine Smallwood; Cedona Pennie; James Anderson; Alvaro G Estévez
Journal:  J Neurochem       Date:  2009-01-19       Impact factor: 5.372

4.  Hemin-induced apoptosis in PC12 and neuroblastoma cells: implications for local neuronal death associated with intracerebral hemorrhage.

Authors:  Yossef S. Levy; Jonathan Y. Streifler; Hanna Panet; Eldad Melamed; Daniel Offen
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

Review 5.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

6.  Mitigation of peroxynitrite-mediated nitric oxide (NO) toxicity as a mechanism of induced adaptive NO resistance in the CNS.

Authors:  Amy Bishop; Renea Gooch; Asuka Eguchi; Stephanie Jeffrey; Lorraine Smallwood; James Anderson; Alvaro G Estevez
Journal:  J Neurochem       Date:  2009-01-13       Impact factor: 5.372

Review 7.  Hydrogen sulfide as a gasotransmitter.

Authors:  Moataz M Gadalla; Solomon H Snyder
Journal:  J Neurochem       Date:  2010-01-12       Impact factor: 5.372

8.  Regulation and expression of heme oxygenase enzymes in aged-rat brain: age related depression in HO-1 and HO-2 expression and altered stress-response.

Authors:  J F Ewing; M D Maines
Journal:  J Neural Transm (Vienna)       Date:  2006-02-16       Impact factor: 3.575

Review 9.  Molecular basis of vascular events following spinal cord injury.

Authors:  Crina Sinescu; Florian Popa; Valentin Titus Grigorean; Gelu Onose; Aurelia Mihaela Sandu; Mihai Popescu; Gheorghe Burnei; Victor Strambu; Constantin Popa
Journal:  J Med Life       Date:  2010 Jul-Sep

10.  P45 forms a complex with FADD and promotes neuronal cell survival following spinal cord injury.

Authors:  Tsung-Chang Sung; Zhijiang Chen; Sandrine Thuret; Marçal Vilar; Fred H Gage; Roland Riek; Kuo-Fen Lee
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.